Cholesterol-Lowering Therapy : Evaluation of Clinical Trial Evidence Book

Cholesterol-Lowering Clinical Trials: A Historical Perspective Scott M. Grundy Scandinavian Simvastatin Survival Study (4S)
Terje R. Pedersen The Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, C. Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene Braunwald Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS)
James Shepherd and Allan Gaw Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study Henry Buchwald The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Primary Prevention of Acute Major Coronary Events in Women and Men with Average Cholesterol Stephen Weis, Michael Clearfield, Lt. Col. John R. Downs, and Antonio M. Gotto, Jr.
Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular Practice Andrew M. Tonkin and David Hunt Angiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-Analysis Cheryl L. Holmes, Michael Schulzer, and G. B. John Mancini Biochemical Correlates of Plaque Progression and Coronary Events Melissa Ferraro-Borgida and David Waters Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular Events B. Greg Brown and Xue-Qiao Zhao Cholesterol-Lowering Trials with Carotid Ultrasonographic Outcomes Robert P. Byington Cholesterol Lowering Reduces Mortality: The Statins David J. Gordon